Effect of miR-17-92 on Multidrug Resistance of Acute Lymphocytic Leukemia Cell Line
Fengqin Shi, Yamei Xu, Rao Enyu, Yayue Zhang, Wei Ma, Zhao Yong, Xinyi Chen
Abstract
Fengqin Shi, Yamei Xu, Rao Enyu, Yayue Zhang, Wei Ma, Zhao Yong, Xinyi Chen
Abstract
Objective: To investigate the possible role of miR-17-92 in the development of multidrug resistance(MDR)in Acute Lymphocytic Leukemia cell line L1210/DDP.Methods: L1210 cell line resistant to DDP(L1210/DDP) was established.Real-time PCR analysis was used to detect the expression of miR-17-92 between multidrug-resistant acute lymphocytic leukemia cell line L1210/DDP and its parental L1210 cell line.L1210/DDP cells were transfected with the inhibition of miR-17-92(miR-17-92 sponge) or negative control(sponge vector) by Lipofectamine 2000 to down-regulate the expression level of miR-17-92 in L1210/DDP cells.MTS was used to analyze drug sensitivity to DDP and ADR after transfection.Results: miR-17-92 has high expression in multidrug-resistant acute lymphocytic leukemia cell line L1210/DDP.In vitro drug sensitivity assay showed that the down-regulation of miR-17-92 sensitized L1210/DDP cells to anticancer drugs of DDP and ADR.Conclusion: miR-17-92 has high expression in L1210/DDP cell line.Inhibition of miR-17-92 can sensitize L1210/DDP cell to DDP and ADR,reverse drug resistance in part.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the possible role of miR-17-92 in the development of multidrug resistance(MDR)in Acute Lymphocytic Leukemia cell line L1210/DDP.Methods: L1210 cell line resistant to DDP(L1210/DDP) was established.Real-time PCR analysis was used to detect the expression of miR-17-92 between multidrug-resistant acute lymphocytic leukemia cell line L1210/DDP and its parental L1210 cell line.L1210/DDP cells were transfected with the inhibition of miR-17-92(miR-17-92 sponge) or negative control(sponge vector) by Lipofectamine 2000 to down-regulate the expression level of miR-17-92 in L1210/DDP cells.MTS was used to analyze drug sensitivity to DDP and ADR after transfection.Results: miR-17-92 has high expression in multidrug-resistant acute lymphocytic leukemia cell line L1210/DDP.In vitro drug sensitivity assay showed that the down-regulation of miR-17-92 sensitized L1210/DDP cells to anticancer drugs of DDP and ADR.Conclusion: miR-17-92 has high expression in L1210/DDP cell line.Inhibition of miR-17-92 can sensitize L1210/DDP cell to DDP and ADR,reverse drug resistance in part.
Key concepts: L1210 cells, Cell culture, Multiple drug resistance, Lipofectamine, Drug resistance, Transfection, Chronic lymphocytic leukemia, Leukemia